Concepedia

Susan Grange

SG

12

Publications

780

Citations

12

H-Index

1995

Active since

Affiliations

Roche (Switzerland)(Current)

La Roche College

Roche (United Kingdom)

Cancer Research UK

Susan Grange is an author at Roche (Switzerland) specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

1995–2016

12

Publications

12

Disease–Drug–Drug Interaction Involving Tocilizumab and Simvastatin in Patients With Rheumatoid Arthritis

Christophe Schmitt, Bernd Kuhn, X Zhang et al. · Clinical Pharmacology & Therapeutics · 2011 · 250 citations

Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis

Nicolas Frey, Susan Grange, Thasia Woodworth · The Journal of Clinical Pharmacology · 2010 · 118 citations

, , +15

Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study*

Lars F. Gram, Theodor W. Guentert, Susan Grange et al. · Clinical Pharmacology & Therapeutics · 1995 · 99 citations

Significant Effect of Capecitabine on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Cancer

D. Ross Camidge, Bruno Reigner, Jim Cassidy et al. · Journal of Clinical Oncology · 2005 · 68 citations

Unexpected Hepatotoxicity of Rifampin and Saquinavir/Ritonavir in Healthy Male Volunteers

Christophe Schmitt, Myriam Riek, Katie Winters et al. · Archives of Drug Information · 2009 · 67 citations · Full text

, , +19

Rows per page

1–5 of 12